List of Excipients in API metoprolol succinate and hydrochlorothiazide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing metoprolol succinate and hydrochlorothiazide
Detailed excipient profiles for metoprolol succinate and hydrochlorothiazide
Excipient focus: CELLULOSE, MICROCRYSTALLINE
metoprolol succinate and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | metoprolol succinate and hydrochlorothiazide | 59212-087 |
| >Company | >Ingredient | >NDC |
metoprolol succinate and hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSES
metoprolol succinate and hydrochlorothiazide drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | metoprolol succinate and hydrochlorothiazide | 59212-087 |
| >Company | >Ingredient | >NDC |
metoprolol succinate and hydrochlorothiazide drug variants not containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
metoprolol succinate and hydrochlorothiazide drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | metoprolol succinate and hydrochlorothiazide | 59212-087 |
| >Company | >Ingredient | >NDC |
metoprolol succinate and hydrochlorothiazide drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
metoprolol succinate and hydrochlorothiazide drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | metoprolol succinate and hydrochlorothiazide | 59212-087 |
| >Company | >Ingredient | >NDC |
metoprolol succinate and hydrochlorothiazide drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
metoprolol succinate and hydrochlorothiazide drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | metoprolol succinate and hydrochlorothiazide | 59212-087 |
| >Company | >Ingredient | >NDC |
metoprolol succinate and hydrochlorothiazide drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PARAFFIN
metoprolol succinate and hydrochlorothiazide drug variants containing PARAFFIN
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | metoprolol succinate and hydrochlorothiazide | 59212-087 |
| >Company | >Ingredient | >NDC |
metoprolol succinate and hydrochlorothiazide drug variants not containing PARAFFIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
metoprolol succinate and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | metoprolol succinate and hydrochlorothiazide | 59212-087 |
| >Company | >Ingredient | >NDC |
metoprolol succinate and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K15
metoprolol succinate and hydrochlorothiazide drug variants containing POVIDONE K15
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | metoprolol succinate and hydrochlorothiazide | 59212-087 |
| >Company | >Ingredient | >NDC |
metoprolol succinate and hydrochlorothiazide drug variants not containing POVIDONE K15
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
metoprolol succinate and hydrochlorothiazide drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | metoprolol succinate and hydrochlorothiazide | 59212-087 |
| >Company | >Ingredient | >NDC |
metoprolol succinate and hydrochlorothiazide drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
metoprolol succinate and hydrochlorothiazide drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | metoprolol succinate and hydrochlorothiazide | 59212-087 |
| >Company | >Ingredient | >NDC |
metoprolol succinate and hydrochlorothiazide drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
metoprolol succinate and hydrochlorothiazide drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | metoprolol succinate and hydrochlorothiazide | 59212-087 |
| >Company | >Ingredient | >NDC |
metoprolol succinate and hydrochlorothiazide drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
metoprolol succinate and hydrochlorothiazide drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | metoprolol succinate and hydrochlorothiazide | 59212-087 |
| >Company | >Ingredient | >NDC |
metoprolol succinate and hydrochlorothiazide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
